Advanced analytical methods are speeding up the targeted evaluation of potential viral contaminants.
Advanced analytical methods are speeding up the targeted evaluation of potential viral contaminants.
Read this article
from BioPharm International’s 2014 Analytical and Bioanalytical eBook.
MHRA Approves GSK Therapy Combinations for Multiple Myeloma
April 21st 2025Belantamab mafodotin is approved in combination with bortezomib plus dexamethasone in patients who have had at least one prior therapy, and in combination with pomalidomide plus dexamethasone for those who have had a prior therapy including lenalidomide.